Cryoprecipitate-induced mesenteric venous thrombosis during L-asparaginase therapy for acute lymphoblastic leukaemia

Leukemia and Lymphoma

Volumn 40, Issue 3-4, 2001, Pages 429-431

  Musa, M O ^a   Al Fair, F ^a   Al Mohareb, F ^a   Al Saeed, H ^a   Aljurf, M ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

Acute lymphoblastic leukaemia; Cyroprecipitate; L asparaginase; Mesenteric venous thrombosis

Indexed keywords

ANTITHROMBIN III; ASPARAGINASE; FIBRINOGEN; FRESH FROZEN PLASMA; IDARUBICIN; PREDNISOLONE; PROTEIN C; PROTEIN S; VINCRISTINE;

ABDOMINAL PAIN; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BLEEDING; BLEEDING DISORDER; BLOOD; CASE REPORT; CLINICAL FEATURE; CRYOPRECIPITATE; DEATH; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; GANGRENE; HUMAN; INTESTINE; LAPAROTOMY; MALE; MESENTERIC VEIN THROMBOSIS; PRIORITY JOURNAL; SKIN DISEASE; THROMBOCYTOPENIA;

EID: 0035035486     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109057944     Document Type: Article

References (11)

1. Hypofibrinoginemia and coagulation factor deficiencies with L-asparaginase treatment
2. Increased endogenous thrombin generation in children with acute lymphoblastic leukaemia: Risk of thrombotic complications in L-asparaginase-induced anti-thrombin III deficiency
3. Thrombotic complications during L-asparaginase treatment for acute lymphocytic leukaemia
4. The GIMEMA Group: Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy. A retrospective study
5. Cerebrovascular complications of L-asparaginase therapy
6. Sequelae of thrombotic or haemorrhagic complications following L-asparaginase therapy for childhood lymphoblastic leukaemia
7. A regimen for anti-thrombin III substitution in patients with acute lymphoblastic leukaemia under treatment with L-asparaginase
8. Inefficacy of fresh frozen plasma in the treatment of L-asparaginase induced coagulation factor deficiencies during ALL induction therapy
9. Effects of Erwinia-asparaginase on the coagulation system
10. L-asparaginase in acute lymphoblastic leukaemia treatment: The role of antithrombin III concentrates in regulating the prothrombotic state induced by therapy
11. A prospective evaluation of thrombotic risk in children with acute lymphoblastic leukaemia carrying the TT677 genotype, the prothrombin G20210A variant and further prothrombotic risk factors